The reason to test hormone levels before treatment comes down to one clinical fact: symptoms of testosterone deficiency overlap with conditions that have nothing to do with testosterone. Fatigue, low libido, and loss of muscle mass appear in obesity, depression, sleep apnea, and opioid use. Blood work is what separates a real deficit from a mimic.
Hormone level testing measures total testosterone on 2 separate morning draws, combined with symptom evaluation and labs such as LH and FSH. Both the Endocrine Society and AUA require this 2-draw protocol (Bhasin et al., 2018; Mulhall et al., 2018) because about 30% of men with a first low result return to normal on retest (Bhasin et al., 2018). The Endocrine Society specifies fasting; the AUA requires early-morning collection but does not mandate fasting.
A 2026 chart review found only 12% of new testosterone prescriptions met the full guideline workup (Sinha et al., 2026). At Marek Diagnostics, every testosterone panel follows that standard from the first draw.
Symptoms That Signal a Need for Hormone Testing
The Endocrine Society lists reduced libido, erectile difficulty, fatigue, depressed mood, reduced concentration, and loss of muscle mass as symptoms associated with testosterone deficiency (Bhasin et al., 2018). None is specific to low testosterone. Each appears in thyroid disease, iron deficiency, poorly controlled diabetes, and chronic sleep debt.
That distinction is why guidelines tie testing to symptoms rather than population screening. The 2026 Endocrine Society statement reinforced that screening asymptomatic men isn't recommended (Endocrine Society, 2026). Symptoms prompt the blood draw. The blood draw provides the objective data a provider uses, alongside symptoms and clinical context, to determine whether a deficiency is present. Treatment follows only when both align.
Low Testosterone Overlaps With Common Metabolic Conditions
A 2026 NHANES analysis of 10,357 U.S. men found 25.7% had total testosterone below 300 ng/dL (Goulian et al., 2026). Obesity carried the strongest independent association, with an adjusted odds ratio of 2.69.
That number doesn't mean 1 in 4 men has hypogonadism. The European Male Ageing Study found that only 2.1% of men ages 40-79 met the full definition of late-onset hypogonadism when sexual symptoms were required alongside low testosterone (Wu et al., 2010). The gap between a biochemical cutoff and a clinical diagnosis is wide, and individual biomarker interpretation matters more than a single number.
Obesity and type 2 diabetes lower sex hormone-binding globulin (SHBG), which can push total testosterone below 300 ng/dL while calculated free testosterone remains in range. In that setting, a low total testosterone reflects a binding-protein shift, not necessarily a true deficit. Opioid use, by contrast, suppresses the hypothalamic-pituitary axis and typically lowers both total and free testosterone. Starting treatment based on total testosterone alone without distinguishing the mechanism means treating a lab artifact in some cases and missing a central cause in others.
When Does Draw Timing or Fasting Status Affect Results?
The Endocrine Society specifies fasting morning draws (Bhasin et al., 2018). The AUA requires early-morning collection but does not mandate fasting or a specific time window (Mulhall et al., 2018). Testosterone peaks in the early morning and drops through the day, sometimes by 20-30% by afternoon. Food intake blunts the peak further.
An afternoon, post-meal sample can place a man below 300 ng/dL who would have tested at 400 ng/dL that same morning. Guidelines require 2 draws on separate mornings, on the same assay and lab, to confirm consistency.
For men preparing for blood work, following the Endocrine Society protocol takes 2 visits. Fast overnight, draw in the morning, then repeat on a separate day. A non-fasting afternoon draw is one of the most common reasons for a falsely low result in outpatient testosterone testing. Skipping either step introduces error that can change a clinical decision.
Does Every Man Over 40 Need a Testosterone Test?
No. The Endocrine Society and the 2026 statement both recommend against screening asymptomatic men (Bhasin et al., 2018; Endocrine Society, 2026). Testing follows symptoms, not a birthday.
Testosterone does decline with age. Longitudinal data show an approximate 1% annual decline in total testosterone after age 40, though the rate varies by body weight, comorbidities, and assay method. The 2026 Endocrine Society statement specifically warned against terms like "age-related hypogonadism" because they blur disease and normal aging.
Men with unexplained fatigue, persistent erectile difficulty, loss of muscle mass, or depressed mood alongside metabolic risk factors have the clearest indication for testing. Men without symptoms generally don't. Understanding how Marek's process works starts with clinical judgment, not a blanket age-based recommendation.
Why Test Hormone Levels Before Starting Any Prescription
Testosterone is a Schedule III controlled substance. Prescribing it requires a legitimate medical purpose, confirmed by lab work and clinical evaluation. No guideline supports starting therapy on symptoms alone.
The lab panel before a first prescription should include, at minimum:
|
Lab |
Purpose |
|
Total testosterone (2 early-morning draws, fasting per ES) |
Confirm persistently low testosterone |
|
LH and FSH |
Distinguish primary from secondary hypogonadism |
|
Hematocrit |
Baseline; monitored per guideline thresholds on treatment |
|
PSA (men over 40) |
Pretreatment prostate screen |
|
Prolactin (if LH is low) |
Rule out pituitary disease |
|
SHBG or free testosterone |
Clarify borderline total testosterone |
Source: Endocrine Society 2018 and AUA 2018 guidelines.
Skipping LH and FSH means missing the distinction between testicular failure and a pituitary or hypothalamic problem that may need imaging. A prolactin-secreting adenoma is uncommon, but it's why the extra labs exist. Skipping hematocrit means missing a well-established lab-triggered reason to pause treatment.
Treatment decisions are individualized and made in partnership between the provider and client based on symptoms, lab findings, health history, and personal goals. Marek Diagnostics' lab builder includes these markers, and providers evaluate results before any prescription is written. Exogenous testosterone suppresses sperm production, sometimes severely. Recovery after discontinuation is unpredictable and may be incomplete. Men who may want biological children should discuss fertility preservation options with their provider before starting therapy. Those ready to schedule a consultation can start with the lab work that makes the conversation specific.
How Reliable Are At-Home Hormone Testing Kits?
At-home testosterone tests collect saliva or a finger-prick blood spot and send results to a lab. Accuracy varies by manufacturer, sample type, and collection conditions. The Endocrine Society advises against analog free-testosterone immunoassays because they aren't accurate at low concentrations (Bhasin et al., 2018).
A finger-prick blood spot for total testosterone is closer to a venous draw, but collection technique, sample volume, and temperature during shipping all introduce variability. No at-home kit replaces the guideline protocol: 2 venous early-morning draws on an assay certified through the CDC's Hormone Standardization Program, which requires mean bias within 6.4% of the reference method. The harmonized reference range for those assays is 264-916 ng/dL (Travison et al., 2017). As of April 2026, the CDC's certified assay list is publicly available and can be checked before ordering a test.
Pre-built lab panels through a clinical provider use venous blood processed by accredited labs. That removes the sample-handling variables that limit at-home kits for clinical decisions.
Lifestyle Factors That Affect Testosterone Levels
Sleep, body composition, alcohol intake, and resistance training all influence testosterone concentrations. This is well established and doesn't require a prescription to address.
Obesity is the strongest modifiable predictor. The 2026 NHANES analysis found an adjusted odds ratio of 2.69 for biochemical testosterone below 300 ng/dL in men with obesity (Goulian et al., 2026). Weight loss, better sleep, and reduced alcohol consumption can raise total testosterone without medication in men whose deficit is driven primarily by metabolic factors. Resistance training shows modest, typically transient associations with higher testosterone in short-term studies, though the magnitude varies by age and program design.
Testing both before and after lifestyle changes measures whether the deficit was reversible. Men exploring metabolic biomarkers or check-up panels can track glucose, lipids, and inflammation alongside testosterone to see the full picture.
Testosterone responds to the same inputs that drive metabolic health. Testing is what shows whether those inputs resolved a deficit or whether a diagnosed deficiency persists despite changes. That clinical answer is the reason to test hormone levels at the start and again after intervention.
Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.
FAQs
Why do guidelines require 2 blood draws to test hormone levels?
Testosterone fluctuates by time of day, food intake, and assay precision. About 30% of men whose first morning draw falls below 300 ng/dL return to normal on a second test (Bhasin et al., 2018). The AUA rates the 2-draw requirement as a Strong Recommendation with Grade A evidence (Mulhall et al., 2018). A single measurement isn't reliable enough to base a prescription on.
Can a provider diagnose low testosterone from symptoms alone?
No. Fatigue, reduced libido, and depressed mood are nonspecific. The European Male Ageing Study found 17% of men ages 40-79 had biochemical low testosterone, but only 2.1% met the full symptomatic definition of late-onset hypogonadism (Wu et al., 2010). Both the Endocrine Society and AUA require symptoms plus confirmed low testosterone on lab work.
What is the difference between total and free testosterone?
Total testosterone measures all circulating testosterone. Free testosterone measures the fraction not bound to SHBG or albumin. Obesity lowers SHBG and can push total testosterone below 300 ng/dL while free testosterone remains normal (Goulian et al., 2026). The Endocrine Society recommends measuring free testosterone when total testosterone is borderline or when SHBG is likely altered.
Why test hormone levels if I feel fine but my number is low?
A low number without symptoms generally doesn't meet the clinical definition of hypogonadism. The Endocrine Society requires both low testosterone and consistent symptoms for a diagnosis. Population screening of asymptomatic men isn't recommended. A low lab value alone may reflect the assay, the time of day, or a temporary condition like acute illness rather than a lasting deficiency.
Does testosterone testing require fasting?
The Endocrine Society specifies fasting morning draws (Bhasin et al., 2018). The AUA requires early-morning collection but does not mandate fasting (Mulhall et al., 2018). Testosterone drops 20-30% from morning to afternoon, and food intake lowers the peak further, so clinical practice typically follows the stricter standard.
What other labs should be drawn alongside testosterone?
At minimum: LH and FSH to separate primary from secondary hypogonadism, hematocrit to set a baseline before treatment, and PSA for men over 40. If testosterone is low and LH is low or normal, prolactin should be checked. The Endocrine Society also recommends free testosterone or SHBG when total testosterone is near the lower limit or when binding-protein levels may be altered.
Do the TRAVERSE trial results change what monitoring labs are needed?
TRAVERSE showed that testosterone therapy met noninferiority for major cardiac events (7.0% vs 7.3%) but found higher rates of atrial fibrillation (3.5% vs 2.4%), acute kidney injury (2.3% vs 1.5%), and pulmonary embolism on treatment (Lincoff et al., 2023). The FDA added blood-pressure warnings after separate post-market monitoring studies. These findings don't reduce the need for cardiovascular labs. They reinforce it.
References
Share:
Stress And Hormone Levels: What Happens In The Body
TRT Blood Work: How Often To Test And What To Check